Dishman Pharmaceuticals Q3 net up two-fold to Rs 47 cr

Drug firm Dishman Pharmaceuticals and Chemicals today reported a nearly two-fold jump in consolidated net profit to Rs 46.93 crore for the quarter ended December 31.
The company had posted a net profit of Rs 24.03 crore for the corresponding period of the previous fiscal, Dishman Pharmaceuticals and Chemicals said in a BSE filing.
Consolidated total income of the company stood at Rs 388.73 crore for the quarter under consideration as against Rs 389.68 in the same period a year ago.
Dishman Pharmaceuticals and Chemicals shares today closed 7.92 per cent up at Rs 347.65 apiece on the BSE.